Tools
Harm Reduction
HIV/AIDS and Substance Use
AIDS Education & Training Center
Maryland education opportunities for providers from the Institute of Human Virology
Addressing Unhealthy Alcohol Use & HIV Pre‑exposure Prophylaxis Care Continuum
Center for HIV Prevention and Health Services
Prevention and Treatment of HIV Among People Living with Substance Use and/or Mental Disorders
This guide reviews interventions for people living with substance use and mental disorders who are at risk for or living with HIV.
Substance Use and HIV Risk
HIV Prevention: Reducing Risk from Alcohol & Drug Use from HIV.gov
Pain Management
AAFP Chronic Pain Management Toolkit
Designed to help family physicians identify gaps in practice flow, standardize evaluation and treatment of chronic pain patients, and facilitate conversations surrounding pain and treatment goals, as well as identify and mitigate risk.
CDC Clinical Practice Guideline for Prescribing Opioids for Pain
CDC Guide to provide recommendations for the prescribing of opioid pain medication for patients 18 and older in primary care settings.
Maryland State Medical Board Opioid Prescribing Guidelines
In light of the opioid epidemic, the Maryland State Board of Physicians has adopted the following guidance for Maryland physicians and physician assistants to consider when determining whether and how to prescribe opioids.
SCOPE of Pain
Find information, resources and tools about safe and competent opioid prescribing for patients with chronic pain.
SCOPE of Pain Trainer's Toolkit
Interactive Trainer's Toolkit that you can use to train all the clinicians in your facility, practice or health system on all facets of opioid prescribing.
When to refer a patient to a pain specialist (AAPM)
Document to assist primary care providers in providing their patients the best of chronic pain care.
Pregnancy & Parenting
Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants
This Clinical Guide from SAMHSA provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants.
State Options for Promoting Recovery among Pregnant and Parenting Women with Opioid or Substance Use Disorder
The National Academy for State Health Policy (NASHP) interviewed state Medicaid, behavioral health, and public health officials from Colorado, Pennsylvania, and Texas to learn about their unique interagency approaches to treating and supporting pregnant and parenting women with substance use disorder (SUD).
Prescription Drug Monitoring Program (PDMP)
PDMP information on the MDH website
The Maryland Department of Health (MDH) has made access to patient controlled dangerous substance (CDS) prescription information collected by the PDMP available at no-cost to physicians, nurse practitioners, pharmacists, and others who provide medical care to an individual with whom they have an existing treatment relationship. Providers can now register with CRISP to get access to PDMP data to support patient care. See the Clinical Resources section for information on educational and training resources designed to assist providers with safe and effective use of CDS prescription drugs in patient care.
Screening & Prevention Tools
Addressing Alcohol Use Practice Manual (AAFP)
This AAFP practice manual provides a systems-change approach for implementing alcohol SBI into your practice.
Appropriate Use of Drug Testing in Clinical Addiction Medicine (ASAM)
Guidance about the effective use of drug testing in the identification, diagnosis, treatment and promotion of recovery for patients with, or at risk for, addiction.
- Drug Testing Pocket Guide
Download the full ASAM Appropriate Use of Drug Testing in Clinical Addiction Medicine in journal format.
Screening, Brief Intervention, and Referral to Treatment (SBIRT)
SBIRT is an approach to the delivery of early intervention and treatment to people with substance use disorders and those at risk of developing these disorders.
Screening Tools and Prevention (NIDA)
Provides links to evidence-based screening, assessment, and prevention tools and is organized by substance type, patient age, and administration method to help you find the right tool for your practice.
Stigma-Reducing Language
Addiction and Substance Use Disorders: Tips for Communicating without Stigma
A social media strategist at the National Institute on Drug Abuse shares the strategies her organization employs when it comes to avoiding stigmatizing language.
Different forms of stigma and rural primary care professionals' willingness to prescribe buprenorphine
This qualitative study identified three distinct forms of stigma influencing rural primary care providers' willingness to prescribe buprenorphine: stigma towards patients, stigma towards providers and stigma towards buprenorphine itself. These findings underscore the complex nature of stigma as a barrier to buprenorphine access in rural areas and suggest that implementation strategies must address these different forms of stigma to improve prescribing rates.
"Don't Label Us" Campaign
Queen Anne’s County Health Department has developed an award-winning education and stigma-reducing campaign about recovery from substance use disorder.
How to talk with your patients about substance use disorders
Talking with patients about potential substance misuse can be challenging. This overview from the American Medical Association demonstrates how one physician approaches this conversation during his addiction consultations with patients while avoiding stigma in the process.
"Overcoming Addiction, Ending Stigma" Resource Guide
SAMHSA has developed a list of resources about the language of substance use disorder recovery and treatment.
Stigma as a fundamental hindrance to the United States opioid overdose crisis response
This research article examines the role of stigma in responses to the opioid crisis in the United States. It shows how several dimensions of stigma play a role in hindering a response to the crisis.
The Power of Perceptions & Understanding: Changing How We Deliver Treatment & Recovery Services
This four-part webcast series from the Substance Abuse and Mental Health Services Administration educates healthcare professionals about the importance of using approaches that are free of discriminatory attitudes and behaviors in treating individuals with substance use disorders and related conditions, as well as patients in recovery.
Words Matter - Terms to Use and Avoid When Talking About Addiction
NIDA has created a page of tips for providers to keep in mind when using person-first language. It also contains terms to avoid in order to reduce stigma and negative bias when discussing addiction.
Substance Use Consultation Warmlines for Providers Practicing in Other States
National (United Stated)
National Substance Use Warmline
855-300-3595
District of Columbia
District Addiction Consultation Service (DACS)
866-337-DACS (3227)
Arkansas
Medication Assisted Treatment Recovery Initiative for Arkansas Rural Communities (MATRIARC)
833-872-7404
California
California Substance Use Line
844-326-2626
Massachusetts
The Massachusetts Consultation Service for the Treatment of Addiction and Pain (MCSTAP)
1-833-PAIN-SUD (1-833-724-6783)
Michigan
Michigan Opioid Collaborative (MOC)
734-763-9500
Wisconsin
University of Wisconsin Addiction Consultation Provider Hotline
800-472-0111
Know of a United States substance use consultation line for providers that isn't listed?
Let us know! Email crehfield@som.umaryland.edu.
Suicide Prevention
Risk Factors for Suicide among People with Chronic Pain
Current evidence suggests that people who experience chronic pain are at increased risk for a number of adverse health outcomes, including opioid overdose and suicide.
Substance Use and Suicide: A Nexus Requiring a Public Health Approach
SAMHSA's In Brief summarizes the relationship between substance use and suicide and provides state and tribal prevention professionals with information on the scope of the problem, an understanding of traditional barriers to collaboration and current programming, and ways to work together on substance misuse and suicide prevention strategies.
Suicide Prevention Resource Database
An extensive, searchable resource (e.g., articles, tools, fact sheets, reports) and program database developed by SPRC and other suicide prevention organizations and experts.
Supporting Families Impacted by Substance Use
Maryland Substance Exposed Newborn Tool Kit
The purpose of the toolkit is to educate the public, including, community service providers, local agencies, and health professionals, as to best practices for supporting substance exposed newborns and families impacted by substance use.
National Center on Substance Abuse and Child Welfare
Resources that providers and communities can use to better serve families in child welfare affected substance use disorders.
Parental Addiction Resources for Providers (Sesame Street)
Resources to help children and families grow and heal from the impact of parental addiction. Call us at 1-855-337-MACS to request a copy of the Parental Addiction book for your office.
Steps to decrease the impact of parental or household substance use on youth
MACS Fact Sheet
SUD and Parental Addiction Webinars for Providers
Sesame Street in Communities has developed a webinar series focused on substance use disorder and parental addiction to help providers support children and families.
The Role of Primary Care Providers in Decreasing Impact of Parental Addiction (National Association for Children of Addiction)
Family practitioners and others can act as important advocates for appropriate community and school-based prevention approaches and in educating patients and parents.
Treatment Guidelines
Alcohol Use Disorder
Advances in the science and treatment of alcohol use disorder
ASAM Clinical Practice Guideline on Alcohol Withdrawal Management
This clinical guideline provides the latest information to provide guidance on the identification and management of alcohol withdrawal in patients with varying degrees of syndrome severity.
Identification of and Treatment for Unhealthy Alcohol Use in Primary Care Settings
Ways in which family physicians can implement this screening recommendation and then intervene when a patient has a positive screen.
Pharmacotherapy for Alcohol Use Disorder
This PCSS module reviews and compares pharmacological treatment options for individuals with AUD, including acamprosate, disulfiram, and naltrexone (oral and long-acting intramuscular formulations
The NIAAA Alcohol Treatment Navigator®
Today there are more treatment choices than you may expect for your patients or clients with alcohol use disorder (AUD). The NIAAA Alcohol Treatment Navigator will help you find evidence-based care for your patients or clients.
Medications for Opioid Use Disorder
Buprenorphine Formulations: Clinical Best Practice Strategies Recommendations for Perioperative Management of Patients Undergoing Surgical or Interventional Pain Procedures (Pain Physician Journal)
The present investigation aims to review the literature and provide recommendations when encountering a patient on buprenorphine therapy who is scheduled for a surgical or interventional pain procedure.
Buprenorphine Home Induction App (Yale)
An informative mobile application that guides patients on how to conduct Buprenorphine induction using a series of questions that the patient is asked in the mobile application.
Buprenorphine Master Class: Managing Opioid Use Disorder for the Generalist
Treating people with Opioid Use Disorder can be the most rewarding part of your practice! Get comfortable with counseling and pharmacotherapy for OUD with tips from MACS Consultant, Dr. Michael Fingerhood on the Curbsiders, a CME podcast accredited by ACP.
MATx Mobile App for MAT Providers
This free app supports practitioners who currently provide medication-assisted treatment (MAT), as well as those who plan to do so in the future.
Medication Assisted Treatment for Opioid Addiction: Pocket Guide Physicians (SAMHSA)
Condensed, downloadable guide on Medication Assisted Treatment for Opioid Addiction.
Medication Treatment for Opiod Use Disorder in the Primary Care Setting (NIDA)
Getting started: Preparing your practice and treating patients.
Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings
Guidance and step-by-step tactics on implementing opioid use disorder treatment using buprenorphine.
Sublingual & Transmucosal Buprenorphine for OUD: Review and Update (SAMHSA)
This advisory summarizes data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder.
Opioids
AMA Opioid Task Force Recommendations for Physicians
Actions physicians can take to demonstrate leadership and help end the nation’s opioid epidemic.
Opioid Overdose Prevention Toolkit (SAMHSA)
This toolkit offers strategies to health care providers, communities, and local governments for developing practices and policies to help prevent opioid-related overdoses and deaths.
Prevención de la Sobredosis de Opioides Manual de Instrucción (SAMHSA)
Equipa a los proveedores de atención médica, las comunidades y los gobiernos locales con materiales para desarrollar prácticas y políticas para ayudar a prevenir las sobredosis y las muertes relacionadas con los opioides.
Stimulant Use Disorder
Treatment of Stimulant Use Disorders
This guide from SAMHSA supports health care providers, systems, and communities seeking to treat stimulant use disorders. It describes relevant research findings, examines best practices, identifies knowledge gaps and implementation challenges, and offers useful resources.
Substance Use Disorders
Best Practices and Barriers to Engaging People with Substance Use Disorders in Treatment
This study used NCQA-accredited HEDIS data, which captures at least 75 percent of health plans, to identify high performing plans on the IET measure to help assess characteristics and interventions associated with better initiation and engagement of SUD treatment by plan members
Knowledge Application Network (SAMHSA)
Review products used for technical assistance as well as publications and manuals for treatment protocols.
Substance Abuse Confidentiality Regulations
Frequently Asked Questions (FAQs) regarding the Substance Abuse Confidentiality Regulations.
The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder - 2020 Focused Update
Provides the latest information on evidence-based treatment of opioid use disorder (OUD) to guide clinicians in assessing, diagnosing and treating OUD in the United States.
Women
Women
Caring for Women with Opioid Use Disorder: A Toolkit for Organization Leaders and Providers
This HRSA toolkit provides resources and information to bolster care coordination services for women with opioid use disorder.
Provider Substance Use Tools & Resources: Women
Substance Abuse Treatment: Addressing the Specific Needs of Women
This guide from SAMHSA assists providers in offering treatment to women living with substance use disorders.
Women and Opioid Use: The Missing Link in Prevention, Treatment and Recovery
Xylazine
Youth
Education
Approaches to Substance Use and Substance Use Disorders in Youth
Marc Fishman, MD
May 8, 2025
5.8.25 webinar slides
Approaches to Treatment of OUD in the Pediatric Population
Marc Fishman, MD
September 19, 2024
9.19.24 webinar slides
Trends in Adolescent Substance Use: Identification, Screening, and Treatment Planning
Marc Fishman, MD
January 19, 2024
Trends in Youth SUD
Youth Substance Use and Substance Use Disorder
Marc Fishman, MD
May 12, 2023
Addressing Youth Substance Use Slides
Involving Families in Addressing Youth Substance Use
Marc Fishman, MD
October 26, 2022
Involving Families slides
Co occurring Psychiatric and Substance Use Disorders in Youth
Marc Fishman, MD
May 6, 2022
Co occurring Psychiatric and Substance Use Disorders in Youth
Benzodiazepine and prescription stimulant use in youth What’s the impact on SUD and its treatment?
Marc Fishman, MD
September 17, 2021
Treatment of Opioid Use Disorders in Youth
Marc Fishman, MD
December 18, 2020
Treatment of OUD in Youth slides
Youth and Substances: What’s a Primary Care Provider to Do? (BHIPP Resilience Break)
Marc Fishman, MD
September 25, 2020
Youth and Substances slides
Publications
Adolescent substance use: Challenges and opportunities related to COVID-19
Buprenorphine treatment for adolescents and young adults with opioid use disorders: a narrative review
MACS Consultant and Child/Addiction Psychiatrist, Dr. Marc Fishman, is an author
Suspected Nonfatal Drug-Related Overdoses Among Youth in the US: 2016–2019
Treating Youth’s Substance Use Disorder Using Telehealth: Clear Benefits, New Challenges
Resources
CRAFFT substance use screening tool for adolescents aged 12-21
Getting Candid: Resources for providers
Youth Substance Use Prevention, Treatment, and Recovery Resource Guide
Additional Resources
American Society of Addiction Medicine (ASAM)
ASAM is dedicated to increasing access and improving the quality of addiction treatment, educating physicians and the public, supporting research and prevention, and promoting the appropriate role of physicians in the care of patients with addiction.
Behavioral Health Administration (BHA), Maryland Department of Health
Learn more about how Maryland is combatting the heroin and opioid crisis.
National Institute on Alcohol Abuse and Alcoholism Clinician (NIAAA) Resources
Resources for clinicians, physicians, social workers, and other healthcare professionals.
National Institutes on Drug Abuse Clinician Resources (NIDA)
Science-based resources to health professionals on the causes and consequences of drug use and addiction, and advances in pain management.
Opioid Cloud Library
A searchable library of curated, evidence-based resources on opioids and the opioid crisis.
Providers Clinical Support System (PCSS)
These resources for treating OUD and chronic pain were developed for health professionals, patients, family members and significant others of patients and the general community to learn more about the evidence-based treatment of opioid use disorders and the treatment of chronic pain.
Safe medication disposal
Talk to your patients about the most appropriate way to dispose of expired, unwanted and unused medications.
Substance Abuse and Mental Health Services Administration (SAMHSA)
The Substance Abuse and Mental Health Services Administration (SAMHSA) is the agency within the U.S. Department of Health and Human Services that leads public health efforts to advance the behavioral health of the nation. SAMHSA's mission is to reduce the impact of substance abuse and mental illness on America's communities.
U.S. Department of Health & Human Services (HHS) - National Opioid Crisis
Help, resources and information on combating the national opioid epidemic.
The Maryland Addiction Consultation Service is administered by the University of Maryland School of Medicine and funded by the Maryland Department of Health, Behavioral Health Administration.